GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 20751 - 20800 of 39437 in total
PDB ID ▼ UniProt ID Title Descriptor
6EAY Q05320 Structural Basis for Broad Neutralization of Ebolaviruses by an Antibody Targeting the Glycoprotein Fusion Loop
6EAY 6EAY Structural Basis for Broad Neutralization of Ebolaviruses by an Antibody Targeting the Glycoprotein Fusion Loop
6EAQ P0DOX5 Glycosylated FCGR3B / CD16b in complex with afucosylated IgG1 Fc
6EAQ O75015 Glycosylated FCGR3B / CD16b in complex with afucosylated IgG1 Fc
6EAN W8RJF9 CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT F488I STABILIZED IN THE PREFUSION STATE
6EAM W8RJF9 CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT E487D STABILIZED IN THE PREFUSION STATE
6EAI W8RJF9 CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT S398L STABILIZED IN THE PREFUSION STATE
6EAH W8RJF9 CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT K394R-S398L STABILIZED IN THE PREFUSION STATE
6EAF W8RJF9 CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT G143S STABILIZED IN THE PREFUSION STATE
6EAD W8RJF9 CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT F140I STABILIZED IN THE PREFUSION STATE
6EA7 P87666 Structure of EBOV GPcl in complex with the pan-ebolavirus mAb ADI-15878
6EA7 O11457 Structure of EBOV GPcl in complex with the pan-ebolavirus mAb ADI-15878
6EA7 6EA7 Structure of EBOV GPcl in complex with the pan-ebolavirus mAb ADI-15878
6EA5 B8XCN0 Structure of BDBV GPcl in complex with the pan-ebolavirus mAb ADI-15878
6EA5 R4QRC0 Structure of BDBV GPcl in complex with the pan-ebolavirus mAb ADI-15878
6EA5 6EA5 Structure of BDBV GPcl in complex with the pan-ebolavirus mAb ADI-15878
6EA4 Q6P179 ERAP2 bound to Aryl Sulfonamide Uncompetitive Inhibitor
6E9N J7QAK3 E. coli D-galactonate:proton symporter in the inward open form
6E9B A7LY28 Bacteroides ovatus mixed-linkage glucan utilization locus (MLGUL) SGBP-B in complex with mixed-linkage heptasaccharide
6E8Q A6ZSR0 S. CEREVISIAE CYP51 COMPLEXED WITH Posaconazole
6E7X A0A1L8F5J9 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-97
6E7X Q00960 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-97
6E7W A0A1L8F5J9 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-115
6E7W Q00960 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-115
6E7V A0A1L8F5J9 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-88
6E7V Q00960 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-88
6E7U A0A1L8F5J9 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-31
6E7U Q00960 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-31
6E7T A0A1L8F5J9 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-6
6E7T Q00960 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-6
6E7S A0A1L8F5J9 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-5
6E7S Q00960 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-5
6E7R A0A1L8F5J9 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-4
6E7R Q00960 Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor 93-4
6E7K P06858 Structure of the lipoprotein lipase GPIHBP1 complex that mediates plasma triglyceride hydrolysis
6E7K Q8IV16 Structure of the lipoprotein lipase GPIHBP1 complex that mediates plasma triglyceride hydrolysis
6E7H Q5EP31 Crystal structure of H5 hemagglutinin mutant Y161A from A/Viet Nam/1203/2004 H5N1 influenza virus in complex with 3'-GcLN
6E7H Q6DQ18 Crystal structure of H5 hemagglutinin mutant Y161A from A/Viet Nam/1203/2004 H5N1 influenza virus in complex with 3'-GcLN
6E7G Q5EP31 Crystal structure of H5 hemagglutinin mutant Y161A from A/Viet Nam/1203/2004 H5N1 influenza virus
6E7G Q6DQ18 Crystal structure of H5 hemagglutinin mutant Y161A from A/Viet Nam/1203/2004 H5N1 influenza virus
6E7D Q91V08 Structure of the inhibitory NKR-P1B receptor bound to the host-encoded ligand, Clr-b
6E7D Q99JB4 Structure of the inhibitory NKR-P1B receptor bound to the host-encoded ligand, Clr-b
6E6B Q91XX6 Crystal structure of the Protocadherin GammaB4 extracellular domain
6E69 P08246 Ortho-substituted phenyl sulfonyl fluoride and fluorosulfate as potent elastase inhibitory fragments
6E62 A8QVT1 Crystal structure of malaria transmission-blocking antigen Pfs48/45 6C in complex with antibody 85RF45.1 Pf48/45, 85RF45.1 Fab heavy chain, 85RF45.1 Fab light chain
6E62 6E62 Crystal structure of malaria transmission-blocking antigen Pfs48/45 6C in complex with antibody 85RF45.1 Pf48/45, 85RF45.1 Fab heavy chain, 85RF45.1 Fab light chain
6E61 A7LY27 Bacteroides ovatus mixed-linkage glucan utilization locus (MLGUL) SGBP-A in complex with mixed-linkage heptasaccharide
6E5P 6E5P Backbone model based on cryo-EM map at 8.5 A of domain-swapped, glycan-reactive, neutralizing antibody 2G12 bound to HIV-1 Env BG505 DS-SOSIP, which was also bound to CD4-binding site antibody VRC03
6E5P Q2N0S6 Backbone model based on cryo-EM map at 8.5 A of domain-swapped, glycan-reactive, neutralizing antibody 2G12 bound to HIV-1 Env BG505 DS-SOSIP, which was also bound to CD4-binding site antibody VRC03
6E5P Q2N0S9 Backbone model based on cryo-EM map at 8.5 A of domain-swapped, glycan-reactive, neutralizing antibody 2G12 bound to HIV-1 Env BG505 DS-SOSIP, which was also bound to CD4-binding site antibody VRC03

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024